ARIAD Pharma (ARIA) Prices 15.3M Offering at $19.60/Share

ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) announced the pricing of an underwritten public offering of 15,307,000 shares of its common stock, at a price to the public of $19.60 per share. The offering is expected to close on or about January 29, 2013, subject to customary closing conditions. In addition, ARIAD has granted the underwriters a 30-day option to purchase up to 2,296,050 additional shares of common stock to cover over-allotments, if any.

J.P. Morgan Securities LLC, Cowen and Company, LLC and Jefferies & Company, Inc. are acting as joint book-running managers and underwriters for the offering. BMO Capital Markets, Leerink Swann LLC, RBC Capital Markets, LLC and UBS Investment Bank are acting as co-managers for the offering.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• enVVeno Medical (NVNO) files $100M mixed shelf
• CoVolt Power files for proposed IPO
• Entera Bio Ltd. (ENTX) files for 134.8M share offering by selling stockholders